Quantcast
Home / Practice Areas / Business and Civil Practice / Maker of Risperdal hit with $1.1 billion fraud verdict

Maker of Risperdal hit with $1.1 billion fraud verdict

The maker of the antipsychotic drug Risperdal has been ordered to pay $1.1 billion for defrauding Arkansas’ Medicaid program.


Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in:







Scroll To Top